# A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck

> **NCT07346196** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Chicago** · enrollment: 90 (estimated)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **DRUG:** Cemiplimab
- **DRUG:** Fianlimab
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT07346196
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-02-07
- **Primary completion:** 2031-08-22
- **Final completion:** 2031-08-22
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07346196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07346196, "A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07346196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*